Marta Bellini

1.8k citations
10 papers · 511 · 1 hit paper · h-index 6

Impact in

  • Genetics top 2%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
    • Hemoglobinopathies and Related Disorders
  • Hematology top 5%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
    • Platelet Disorders and Treatments

Papers in

    • Myeloproliferative Neoplasms: Diagnosis and Treatment 6
    • Hemoglobinopathies and Related Disorders 1
    • Kruppel-like factors research 4

Marta Bellini

8 papers receiving 501 citations

Marta Bellini's Hit Papers

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes 2013 · 391 citations
3910+4+8Years since publication100200300

Peers

Marta Bellini
Comparison fields: 5 of 33
  • Genetics 475
  • Hematology 335
  • Rheumatology 180
  • Molecular Biology 334
  • Internal Medicine 13
Replace Giacomo Coltro with:
Giacomo Coltro Italy
Sabrina Caberlon Italy
Rangit Vallapureddy United States
Shireen Sirhan Canada
Meera Yogarajah United States
Elisa Zuffa Italy
Federico Vozella Italy
Clodagh Keohane United Kingdom
R. Hehlmann Germany
Georg Jeryczynski Austria
Marta Bellini relative to Giacomo Coltro Italy Giacomo Coltro's profile →
Citations per field
00.5×12.3×
Giacomo Coltro · 1×
Citations per year

Countries citing papers authored by Marta Bellini

Since Specialization
Citations

This map shows the geographic impact of Marta Bellini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Bellini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Bellini more than expected).

Fields of papers citing papers by Marta Bellini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Bellini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Bellini. The network helps show where Marta Bellini may publish in the future.

Co-authors

The 25 scholars most cited alongside Marta Bellini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marta Bellini Line = papers co-authored together Marta Bellini links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
Hit paper breakdown →
2013391
2 201450
3 201738
4 202116
5 20166
6 20176
7 20203
8 20231
9 20080
10 20130

About Marta Bellini

Marta Bellini is a scholar working on Genetics, Molecular Biology, Hematology, Rheumatology and Oncology, having authored 10 papers that have together received 511 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Kruppel-like factors research (4 papers), Acute Myeloid Leukemia Research (3 papers), Eosinophilic Disorders and Syndromes (2 papers), Infection Control and Ventilation (1 paper), Cytomegalovirus and herpesvirus research (1 paper), Hemoglobinopathies and Related Disorders (1 paper) and Neonatal Health and Biochemistry (1 paper). The work is most often cited by research in Genetics (475 citations), Hematology (335 citations), Rheumatology (180 citations), Molecular Biology (334 citations) and Internal Medicine (13 citations). Marta Bellini has collaborated with scholars based in Italy, Austria and Australia. Frequent co-authors include Virginia Valeria Ferretti, Elisa Rumi, Emanuela Boveri, Mario Cazzola, Emanuela Sant’Antonio, Daniela Pietra, Cesare Astori, Ilaria Carola Casetti, Tiina Berg and Jelena D. Milosevic Feenstra. Their work appears in journals such as Blood, Oncotarget, Blood Advances, Pharmaceuticals and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact